6 The drug is used primarily in the treatment of schizophrenia, bipolar disorder, and major depressive disorder in adults
Both trials mainly reported CNS events, with no serious AEs
R.Bou-GhariosG.RajferJ.et al (2002)
Available online at: Summary Keywords weight loss, nutrient intake, glucagon-like peptide-1 receptor agonists, nutrition, diet, dietary reference intakes Citation Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
You'll have likely heard of GLP-1 agonists, which are a type of medication that blocks the action of Glucagon-Like Peptide-1 (a hormone that normally promotes insulin release and reduces appetite) and therefore helps people lose weight